References
- Suchon P, et al. Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families. TH Open. 2019; 03(01): e28–e35. DOI: 10.1055/s-0039-1677807
- Germain M, et al. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am. J. Hum. Genet. 2015; 96: 532–542. DOI: 10.1016/j.ajhg.2015.01.019
- Elouej S, Beleza-Meireles A, Caswell R, Colclough K, Ellard S, Desvignes JP, Béroud C, Lévy N, Mohammed S, De Sandre-Giovannoli A. Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL). Metabolism. 2017 Jun; 71: 213–225. DOI: 10.1016/j.metabol.2017.03.011
- Harhouri K, Navarro C, Depetris D, Mattei MG, Nissan X, Cau P, De Sandre-Giovannoli A, Lévy N. MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation. EMBO Mol Med. 2017 Sep; 9(9): 1294–1313. DOI: 10.15252/emmm.201607315
- Renard D, Fourcade G, Milhaud D, Bessis D, Esteves-Vieira V, Boyer A, Roll P, Bourgeois P, Levy N, De Sandre-Giovannoli A. Novel LMNA mutation in atypical Werner syndrome presenting with ischemic disease. Stroke. 2009 Feb; 40(2): e11–4. DOI: 10.1161/STROKEAHA.108.531780
- De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Lévy N. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003 Jun 27; 300(5628): 2055. DOI: 10.1126/science.1084125
- Bacquet J, Stojkovic T, Boyer A, Martini N, Audic F, Chabrol B, Delague V, Levy N, Bonello-Palot N, et al. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation. BMJ Open. 2018 Oct 28; 8(10):
e021632 . DOI: 10.1136/bmjopen-2018-021632 - Chabannon C, Honstettre A, Daufresne L-M, Martin P-M, Bonnetaud C, Birtwisle-Peyrottes I, Romain S, Achache K, Mery O, Bordonne O, et al. Publication of biological samples collections catalogues by tumor banks. Bull. Cancer. 2010; 97: 181–189. DOI: 10.1684/bdc.2009.0963
- Hofman V, Ilie M, Long E, Washetine K, Chabannon C, Figarella-Branger D, Clément B, Mabile L, Cambon-Thomsen A, Boucher P, et al. Measuring the contribution of tumor biobanks to research in oncology: Surrogate indicators and bibliographic output. Biopreserv. Biobank. 2013; 11: 235–244. DOI: 10.1089/bio.2013.0015
- Clavreul A, Soulard G, Lemée J-M, Rigot M, Fabbro-Peray P, Bauchet L, Figarella-Branger D, Philippe and French Glioblastoma Biobank (FGB) network. The French glioblastoma biobank (FGB): a national clinicobiological database. Journal of Translational Medicine. 2019; 17: 133. DOI: 10.1186/s12967-019-1859-6
- Mariette C, Renaud F, Piessen G, et al. The FREGAT biobank: a clinic-biological database dedicated to esophageal and gastric cancers. BMC Cancer. 2018; 18(1): 139. DOI: 10.1186/s12885-018-3991-8
- Kandel M, Allayous C, Dalle S, Mortier L, Dalac S, Dutriaux C, Leccia MT, Guillot B, Saiag P, Lacour JP, Legoupil D, Lesimple T, Aubin F, Beylot-Barry M, Brunet-Possenti F, Arnault JP, Granel-Brocard F, Stoebner PE, Dupuy A, Maubec E, Grob JJ, et al. Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort. European Journal of Cancer. 2018; 105: 33–40. DOI: 10.1016/j.ejca.2018.09.026